Prognostic implications of ST-segment elevation resolution in patients with ST-segment elevation acute myocardial

Tullio Palmerini1, Stefano De Servi, Alessandro Politi

  • 1Istituto di Cardiologia, Policlinico S. Orsola, Università di Bologna, Bologna, Italy.

Insights

ST-segment elevation resolution is a strong predictor of 30-day mortality in acute myocardial infarction patients treated with percutaneous coronary intervention. This finding holds true across various clinical risk profiles and postprocedural flow.

Area of Science:

  • Cardiology
  • Clinical Practice
  • Interventional Cardiology

Background:

  • Limited data exist on ST-segment elevation (STE) resolution's impact on 30-day mortality in contemporary acute myocardial infarction (AMI) patients treated with percutaneous coronary intervention (PCI).
  • The influence of patient risk profiles and Thrombolysis In Myocardial Infarction (TIMI) flow on the prognostic value of STE resolution remains unexplored.

Purpose of the Study:

  • To investigate the association between STE resolution and 30-day mortality in a real-world setting.
  • To determine if patient clinical risk or postprocedural TIMI flow modifies the prognostic significance of STE resolution.

Main Methods:

  • Analysis of the Lombardima observational registry, prospectively collecting data from 3,403 patients with STE-acute myocardial infarction undergoing PCI.
  • Stratification of patients based on clinical risk and assessment of STE resolution and 30-day mortality.

Main Results:

  • ST-segment elevation resolution was observed in 2,452 patients (72%), with a significantly lower 30-day mortality rate (2.4%) compared to those without resolution (11.3%, p <0.001).
  • STE resolution independently predicted lower 30-day mortality across all clinical risk strata.
  • Even in patients with TIMI 3 flow, STE resolution remained a significant independent predictor of 30-day mortality (p <0.0001).

Conclusions:

  • ST-segment elevation resolution is a powerful and independent predictor of 30-day mortality in patients with STE-acute myocardial infarction treated with PCI.
  • This prognostic value is consistent across the spectrum of clinical risk and in patients achieving TIMI 3 flow.

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...